Narinder Pal Bhalla, Chief Officer of Lexeo Therapeutics LXEO, has filed 4 transactions, none an open-market purchase or sale. The latest trade was on 09/24.

Narinder Pal Bhalla

Chief Medical Officer

Company: Lexeo Therapeutics LXEO
First filing: 26/02/17

Trades: 4 trades
Buys / sales: 0 / 0
12-month net buying: No record
Last trade: 09/24

Trading activity

Transactions

No filed transactions.